ImmunoPrecise Antibodies Net Income 2022-2025 | IPA

ImmunoPrecise Antibodies net income from 2022 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
ImmunoPrecise Antibodies Annual Net Income
(Millions of US $)
2024 $-20
2023 $-20
2022 $-13
2021 $-6
ImmunoPrecise Antibodies Quarterly Net Income
(Millions of US $)
2025-01-31 $-15
2024-10-31 $-2
2024-07-31 $-3
2024-04-30 $-13
2024-01-31 $-2
2023-10-31 $-2
2023-07-31 $-3
2023-04-30 $-4
2023-01-31 $-3
2022-10-31 $-6
2022-07-31 $-7
2022-04-30 $-4
2022-01-31 $-3
2021-10-31 $-4
2021-07-31 $-3
2021-04-30 $-4
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.046B $0.018B
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.769B 58.23
Hims & Hers Health (HIMS) United States $14.374B 149.35
Tempus AI (TEM) United States $11.826B 0.00
Doximity (DOCS) United States $10.774B 49.88
IRhythm Technologies (IRTC) United States $4.653B 0.00
Inspire Medical Systems (INSP) United States $3.861B 60.33
Hinge Health (HNGE) United States $3.282B 0.00
Privia Health (PRVA) United States $2.664B 182.08
Enovis (ENOV) United States $1.720B 9.59
Phreesia (PHR) United States $1.560B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Schrodinger (SDGR) United States $1.501B 0.00
Azenta (AZTA) United States $1.357B 63.06
10x Genomics (TXG) United States $1.331B 0.00
Omnicell (OMCL) United States $1.313B 23.17
Evolent Health (EVH) United States $1.086B 92.50
Claritev (CTEV) United States $0.657B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.448B 134.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.337B 746.67
Outset Medical (OM) United States $0.336B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.251B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.156B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
CareCloud (CCLD) United States $0.106B 4.03
Pulmonx (LUNG) United States $0.105B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.094B 0.00
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Healthcare Triangle (HCTI) United States $0.012B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00